Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 156.25 | 80.34 | 112.00 | 101.25 | 1.1062 | 1.7063 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 156.25 | 80.34 | 69.00 | 101.25 | 0.6815 | -0.3663 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 100.00 | 101.25 | 0.9877 | 0.9269 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 156.25 | 80.34 | 89.00 | 101.25 | 0.8790 | 0.3589 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 156.25 | 80.34 | 85.00 | 101.25 | 0.8395 | 0.1839 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 156.25 | 80.34 | 111.00 | 101.25 | 1.0963 | 1.6345 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 156.25 | 80.34 | 97.00 | 101.25 | 0.9580 | 0.7588 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 156.25 | 80.34 | 102.00 | 101.25 | 1.0074 | 1.0447 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 156.25 | 80.34 | 88.00 | 101.25 | 0.8691 | 0.3136 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 156.25 | 80.34 | 74.00 | 101.25 | 0.7309 | -0.2185 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 59.00 | 101.25 | 0.5827 | -0.6036 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 56.00 | 101.25 | 0.5531 | -0.6610 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 381.00 | 443.75 | 0.8586 | 0.6474 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 361.00 | 443.75 | 0.8135 | 0.5382 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 312.50 | 257.33 | 441.00 | 443.75 | 0.9938 | 0.9843 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 312.50 | 257.33 | 532.00 | 443.75 | 1.1989 | 1.5190 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 312.50 | 257.33 | 491.00 | 443.75 | 1.1065 | 1.2747 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 312.50 | 257.33 | 324.00 | 443.75 | 0.7301 | 0.3405 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 382.00 | 443.75 | 0.8609 | 0.6529 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 435.00 | 443.75 | 0.9803 | 0.9500 | |
| SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 312.50 | 257.33 | 534.00 | 443.75 | 1.2034 | 1.5311 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 312.50 | 257.33 | 668.00 | 443.75 | 1.5054 | 2.3651 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 312.50 | 257.33 | 259.00 | 443.75 | 0.5837 | 0.0082 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 312.50 | 257.33 | 568.00 | 443.75 | 1.2800 | 1.7379 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 312.50 | 257.33 | 270.00 | 443.75 | 0.6085 | 0.0630 |